Your browser doesn't support javascript.
loading
Newer Pharmaceutical Agents for STEMI Interventions.
Chakrabarti, Anjan K; Patel, Shalin J; Salazar, Robert L; Gopalakrishnan, Lakshmi; Kumar, Varun; Rastogi, Ujjwal; Singh, Priyamvada; Zorkun, Cafer; Gibson, C Michael.
Afiliación
  • Chakrabarti AK; Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA.
  • Patel SJ; Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA.
  • Salazar RL; Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA.
  • Gopalakrishnan L; Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA; Cardiovascular Division, Department of Medicine, PERFUSE Angiographic Core Laboratories, Data Coordinating Center, Beth Israel Deacon
  • Kumar V; Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA; Cardiovascular Division, Department of Medicine, PERFUSE Angiographic Core Laboratories, Data Coordinating Center, Beth Israel Deacon
  • Rastogi U; Cardiovascular Division, Department of Medicine, PERFUSE Angiographic Core Laboratories, Data Coordinating Center, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA.
  • Singh P; Cardiovascular Division, Department of Medicine, PERFUSE Angiographic Core Laboratories, Data Coordinating Center, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA.
  • Zorkun C; Cardiovascular Division, Department of Medicine, PERFUSE Angiographic Core Laboratories, Data Coordinating Center, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA; Division of Cardiology, Yedikule Education and Research Hospital, Istanbul, Turkey.
  • Gibson CM; Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Deaconess 319, Boston, MA 02215, USA; WikiDoc Foundation (a 509 (a)(1) Charitable Organization), San Francisco, California. Electronic address: mgibson@perfuse.org.
Interv Cardiol Clin ; 1(4): 429-440, 2012 Oct.
Article en En | MEDLINE | ID: mdl-28581961
ABSTRACT
ST-elevation myocardial infarction (STEMI) causes 12.6% of deaths worldwide. Treatment strategies involve early revascularization by percutaneous coronary intervention and/or fibrinolytics, with adjunctive pharmacologic therapy. While antiplatelet therapy remains the cornerstone of pharmacologic management, newer antithrombotic therapies are showing benefit in the reduction of long-term thrombotic events following acute vessel occlusion. Future directions in adjunctive STEMI management include the use of hematopoietic stem cell therapy or growth factors to induce proliferation and differentiation of cardiac myocytes.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Interv Cardiol Clin Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Interv Cardiol Clin Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos